Matinas BioPharma Holdings Inc (MTNB)

0.53 +0.01 (+1.90%) USD  |  NYAM  |  Dec 24, 16:00
0.5234 -0.01 (-1.25%) Pre-Market: 09:00
More

Matinas BioPharma Holdings Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for MTNB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Equillium Inc Upgrade
Tenon Medical Inc Upgrade
Alphatec Holdings Inc Upgrade
Merck & Co Inc Upgrade
Madrigal Pharmaceuticals Inc --